Version 1 du 11 septembre 2020
COVID-19 in Africa: What else?
Philippe Parola, Souleymane Brah, Abdoulaye Djimde, Nadjet Mouffok, Majida Zahraoui, Ali Ould Mohamed Salem Boukhary, Idir Bitam, Mahamadou Ali Thera, Jean-Bernard Lekana-Douki, Eric Adehossi, Moussa Seydi, Jean-Christophe Lagier, Jaafar Heikel, Didier Raoult, Cheikh Sokhna
As recent news or groundbreaking work, the factors which may explain the dampened course of COVID-19 in Africa has been recently discussed in Science (7 August 2020, p 624-626) but we think that a major issue is missing.
We, being Professors of Infectious diseases or microbiology, MD, PhD, coauthors from Algeria, Morocco, Senegal, Niger, Mali, Mauritania, Gabon, and France, all involved in the COVID 19 pandemic in Africa, would like to comment their article with this PERSPECTIVE to JMII discussing the potential role of the large use of chloroquine derivative with or without azithromycin in many African countries, including ours.